Australia's Amplia Therapeutics climbs on receiving grant
** Shares of Amplia Therapeutics ATX.AX rises as much as
11.8% to A$0.095, gaining the most since Aug. 19
** Co received grant funding from Innovation Connections to
support research collaboration with Commonwealth Scientific and
Industrial Research Organisation
** Co says collaboration will focus on developing
formulations of AMP945 for topical application
** Stock hits highest since May 12
** ATX has climbed 6.25% so far this year, as of last close
(Reporting by Navya Mittal in Bengaluru)
((navya.mittal@thomsonreuters.com))
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement